Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report) was the recipient of a significant incre...
The Phase 2 Istaroxime study was successful in multiple endpoints showing promise for how it may be ...
Windtree Therapeutics Inc [NASDAQ: WINT] plunged by -$0.1 during the normal trading session on while...
Windtree Therapeutics Inc (NASDAQ:WINT) shares have trended lower over the past two trading sessions...
At the time of writing, Windtree Therapeutics Inc [WINT] stock is trading at $0.70, down -12.51%. An...